))
Three Drug Chemo Shows Success Against Multiple Myeloma, Heart Attack and Alzheimer's Disease Share Genes, No Need to Discontinue Clopidogrel Before Endarterectomy
Archived series ("Inactive feed" status)
When?
This feed was archived on August 21, 2018 02:49 (
Why? Inactive feed status. Our servers were unable to retrieve a valid podcast feed for a sustained period.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 156751883 series 1198360
Content provided by Insidermedicine Daily News (Audio). All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Insidermedicine Daily News (Audio) or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
(December 10, 2010 - Insidermedicine)
From Michigan - A new drug combination shows success in treating multiple myeloma, according to a report presented at the American Society of Hematology meeting. Researchers administered a combination of carfilzomib, lenalidomide and low-dose dexamethasone in 31 multiple myeloma patients. Results showed an immediate response to the three drug combo, with all patients achieving a 50% reduction of their disease.
From Italy - According to a report published in the Journal of Alzheimer's Disease, heart attacks and Alzheimer's disease share common genes. Studying 1800 people, researchers found a common genetic disposition associated with both heart attacks and Alzheimer's.
And finally, from Minneapolis - Discontinuing clopidogrel prior to carotid endarterectomy may be unnecessary, according to a report published in the Annals of Vascular Surgery. Studying 260 patients who underwent endarterectomy, researchers found that patients who were allowed to continue taking anti-platelet therapy prior to surgery had no increased risk of bleeding complications.
1297 episodes
Share
